Latest Press Releases
View all
TimeHeadline
1m agoNewmark Names Jack Fuchs as President of Global Asset Services and Member of the Executive Committee
29m agoStop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
29m agoNorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
29m agoBetter Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market
1h agoGridAI Technologies Corp. to Present at the Market Movers Investor Summit
Relay Therapeutics Inc logo

Relay Therapeutics Inc

About

Relay Therapeutics Inc (NASDAQ:RLAY) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
Apr 2 2026
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Mar 16 2026
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Feb 26 2026
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Feb 23 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

Financials

Revenue
$15.36 M
Market Cap
$2.23 B
EPS
-1.61

Community Chat

Ask AI

6ix6ixAIEvents